The Melanotan 2 Analysis is a targeted laboratory test designed to confirm the identity, determine the amount, and assess the peptide purity of Melanotan 2 (MT-2) in lyophilised vials and raw active pharmaceutical ingredient (API) powders.
For lyophilised samples, results are reported in milligrams per vial together with peptide purity. Raw API powders can be evaluated using purity in % (m/m) together with peptide purity.
About Melanotan 2
Melanotan 2 (MT-2) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH). It acts as an agonist of melanocortin receptors and has been investigated primarily for its effects on melanin production, pigmentation, and other melanocortin-mediated processes.
Unlike Melanotan 1, Melanotan 2 interacts with several melanocortin receptor subtypes rather than acting predominantly through MC1R. It remains primarily a research compound.
Key Features
- Targeted identification and quantification of Melanotan 2
- Determination of peptide purity
- Suitable for lyophilised vials and raw API powders
- Analysis by HPLC
- Results for lyophilised samples reported in mg per vial and peptide purity
- Alternative result format for raw API powders includes purity in % (m/m) and peptide purity
- Minimum sample amount of one whole unopened vial with lyophilisate
- Minimum sample amount of 30 mg for raw API powders
- Average turnaround time of 7 business days
Analysis Parameters
- Target compound: Melanotan 2
- CAS number: 121062-08-6
- Molecular weight: 1024
- Sequence: Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-NH2
- Testing method: HPLC
- Result format for lyophilised samples: mg per vial and peptide purity
- Result format for raw API powders: Purity in % (m/m) and peptide purity
- Minimum sample amount for lyophilised samples: One whole unopened vial with lyophilisate
- Minimum sample amount for raw API powders: 30 mg in a sealed glass vial to prevent the sample from absorbing moisture
- Average turnaround time: 7 business days
Important Notice
- This analysis is specifically intended for Melanotan 2. It does not automatically screen the sample for Melanotan 1, other melanocortin-related peptides, degradation products, contaminants, or undeclared substances.
- For lyophilised samples, one whole unopened vial containing lyophilisate is required.
- Raw API powder should be supplied as at least 30 mg in a sealed glass vial to minimise moisture absorption.
- The alternative result format for raw API powders includes both purity in % (m/m) and peptide purity.
Optional Additional Analyses
The following optional laboratory services are available:
- TFA Analysis
- Complete Raw Analytical Data
- Fentanyl Screening
- Alternative Result Format: Purity in % (m/m)
- Batch Variance Testing
- pH Measurement
- Endotoxin Analysis
- CHNS Mass Report
- LCMS Screening for Peptide Contamination
- Sterility Testing (TAMC + TYMC)
- Heavy Metals Analysis (As, Cd, Pb, Hg)
- Additional Laboratory Report
